Therapeutic delivery systems need to focus on cellular precision to target neurodegeneration
The central problem when delivering drugs to the brain is no longer crossing the blood-brain barrier, but delivering therapeutics to the right cells, in the right regions to target neurodegeneration, within a dynamically changing neurovascular unit.
Authors
- Ebru Ercan-Herbst (ORCID: https://orcid.org/0000-0002-6575-6672)
- Sinem Ağılkaya
- Kim Susann Keller
- Lavanya Gupta
Institutions
- Reutlingen University (DE)
Publication Details
- Journal
- PLoS Biology
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1371/journal.pbio.3004049
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Carl-Zeiss-Stiftung
- Bundesministerium für Bildung und Forschung